Papers - HATAKEYAMA SHINGO
-
特集 泌尿器科医のためのクリニカル・パール-いま伝えたい箴言・格言・アフォリズム〈腫瘍/処置・救急・当直編〉 〈腫瘍〉 筋層浸潤性膀胱癌のクリニカル・パール
畠山 真吾, 米山 高弘, 大山 力
臨床泌尿器科 74 ( 11 ) 838 - 843 2020.10
-
Prognosis of metastatic castration‐resistant prostate cancer in the era of the second‐generation androgen receptor‐targeted agents: A retrospective multicenter study
Hiromichi Iwamura, Shingo Hatakeyama, Shintaro Narita, Yoichi Arai, Tomonori Habuchi, Chikara Ohyama
International Journal of Urology 28 ( 1 ) 125 - 127 2020.10
-
Pre-dialysis serum creatinine as an independent predictor of responsiveness to zinc supplementation among patients on hemodialysis.
Teppei Okamoto, Shingo Hatakeyama, Kyo Togashi, Tomoko Hamaya, Yoshimi Tanaka, Kengo Imanishi, Tooru Takashima, Fumitada Saitoh, Tadashi Suzuki, Chikara Ohyama
Clinical and experimental nephrology 24 ( 10 ) 955 - 962 2020.10
-
Safety and Feasibility of Radiation Therapy to the Primary Tumor in Patients With Metastatic Castration-resistant Prostate Cancer.
Fujita N, Hatakeyama S, Momota M, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Mariya Y, Ohyama C
Clinical genitourinary cancer 18 ( 5 ) e523 - e530 2020.10
-
転移性腎細胞癌の一次治療におけるニボルマブ・イピリムマブ併用療法とTKIの比較検討
細越 正吾, 畠山 真吾, 沼倉 一幸, 田中 壽和, 及川 真亮, 野呂 大輔, 成田 伸太郎, 井上 高光, 米山 高弘, 伊藤 弘之, 西村 祥二, 川口 俊明, 橋本 安弘, 羽渕 友則, 大山 力
日本癌治療学会学術集会抄録集 58回 P - 289 2020.10
-
Editorial Comment to Successful pembrolizumab treatment in a patient with metastatic urothelial carcinoma and underlying overlap syndrome involving systemic sclerosis and systemic lupus erythematosus.
Shingo Hatakeyama, Chikara Ohyama
IJU case reports 3 ( 5 ) 183 - 184 2020.9
-
経尿道的尿管砕石術における1人抽石法の有効性と安全性 レーザー使用量を抑え尿路損傷を減らす取り組み
阿南 剛, 畠山 真吾, 小羽田 悠貴, 三上 穣太郎, 伊藤 淳, 海法 康裕, 米山 高弘, 橋本 安弘, 大山 力, 佐藤 信
日本レーザー医学会誌 41 ( 3 ) 261 - 261 2020.9
-
Efficacy and safety of nivolumab for renal cell carcinoma in patients over 75 years old from multiple Japanese institutes.
Kazuyuki Numakura, Mizuki Kobayashi, Shingo Hatakeyama, Sei Naito, Yohei Horikawa, Toshikazu Tanaka, Sachiko Kamada, Yumina Muto, Ryohei Yamamoto, Atsushi Koizumi, Taketoshi Nara, Sohei Kanda, Mitsuru Saito, Shintaro Narita, Takamitsu Inoue, Naotake Shimoda, Norihiko Tsuchiya, Chikara Ohyama, Tomonori Habuchi
International journal of clinical oncology 25 ( 8 ) 1543 - 1550 2020.8
-
Utility of plasma cell-free DNA in metastatic castration-resistant prostate cancer.
Itsuto Hamano, Shingo Hatakeyama, Tomoko Hamaya, Kyo Togashi, Teppei Okamoto, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
IJU case reports 3 ( 4 ) 141 - 144 2020.7
-
Association of tumor burden with the eligibility of upfront intensification therapy in metastatic castration-sensitive prostate cancer: A multicenter retrospective study.
Shingo Hatakeyama, Shintaro Narita, Masahiro Takahashi, Toshihiko Sakurai, Sadafumi Kawamura, Senji Hoshi, Masanori Ishida, Toshiaki Kawaguchi, Shigeto Ishidoya, Jiro Shimoda, Hiromi Sato, Itsuto Hamano, Teppei Okamoto, Koji Mitsuzuka, Akihiro Ito, Norihiko Tsuchiya, Yoichi Arai, Tomonori Habuchi, Chikara Ohyama
International journal of urology : official journal of the Japanese Urological Association 27 ( 7 ) 610 - 617 2020.7
-
Survey on attitudes toward brain-dead and living donor transplantation in medical students: a cross-sectional study in Japan.
Itsuto Hamano, Shingo Hatakeyama, Hayato Yamamoto, Takeshi Fujita, Reiichi Murakami, Michiko Shimada, Atsushi Imai, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Hisao Saitoh, Tadashi Suzuki, Hirofumi Tomita, Chikara Ohyama
Clinical and experimental nephrology 24 ( 7 ) 638 - 645 2020.7
-
Frailty is a predictor of moderate to severe pain after robot-assisted laparoscopic prostatectomy: A case-control study (FRAP study).
Momota M, Hatakeyama S, Soma O, Hamano I, Fujita N, Okamoto T, Togashi K, Hamaya T, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C
BJUI compass 1 ( 3 ) 100 - 107 2020.7
-
Utility of plasma cell‐free DNA in metastatic castration‐resistant prostate cancer
Itsuto Hamano, Shingo Hatakeyama, Tomoko Hamaya, Kyo Togashi, Teppei Okamoto, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
IJU Case Reports 3 ( 4 ) 141 - 144 2020.6
-
尿路結石バイオマーカーとして尿中糖鎖変異オステオポンチン(PolyLacNAc-OPN)の同定
阿南 剛, 米山 徹, 野呂 大輔, 飛澤 悠葵, 畠山 真吾, 米山 美穂子, 山本 勇人, 今井 篤, 伊藤 淳, 海法 康裕, 米山 高弘, 橋本 安弘, 佐藤 信, 大山 力
泌尿器科紀要 66 ( 6 ) 180 - 180 2020.6
-
The impact of microalbuminuria on overactive bladders: Results from a community‐based four‐year longitudinal study in Japan
Teppei Okamoto, Shingo Hatakeyama, Masataka Ando, Jung Songee, Atsushi Imai, Itsuto Hamano, Naoki Fujita, Akiko Okamoto, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
Neurourology and Urodynamics 39 ( 5 ) 1567 - 1575 2020.5
-
特集 ここが変わった! 膀胱癌診療-新ガイドラインを読み解く StageⅡおよびⅢ膀胱癌の治療
濱野 逸人, 畠山 真吾, 大山 力
臨床泌尿器科 74 ( 5 ) 312 - 315 2020.4
-
増刊号特集 泌尿器科診療の最新スタンダード-平成の常識は令和の非常識 腫瘍 部位別 膀胱癌:手術治療(膀胱全摘除術)
畠山 真吾, 米山 高弘, 大山 力
臨床泌尿器科 74 ( 4 ) 45 - 48 2020.4
-
Unusual presentation of upper urinary tract urothelial carcinoma in Taiwan: Direct comparison from Taiwan‐Japan UTUC Collaboration Cohort
Hao Lun Luo, Chikara Ohyama, Shingo Hatakeyama, Hung Jen Wang, Tohru Yoneyama, Wen Chou Yang, Yao Chi Chuang, Yen Ta Chen, Wei Chin Lee, Yuan Tso Cheng, Chih Hsiung Kang, Po Hui Chiang
International Journal of Urology 27 ( 4 ) 327 - 332 2020.4
-
特集 Cl-:電解質のクイーン 臨床とCl- 尿路変向術に伴う高Cl血症
濱野 逸人, 畠山 真吾, 大山 力
腎と透析 88 ( 3 ) 411 - 414 2020.3
-
The association between serum serotonin levels and overactive bladder: results from a community-based cross-sectional study in Japan.
Teppei Okamoto, Shingo Hatakeyama, Atsushi Imai, Hayato Yamamoto, Tohru Yoneyama, Kazuyuki Mori, Takahiro Yoneyama, Yasuhiro Hashimoto, Shigeyuki Nakaji, Chikara Ohyama
World journal of urology 2020.3